These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

38 related items for PubMed ID: 8990941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diabetic retinopathy and urinary albumin excretion rate in type II (non-insulin-dependent) diabetic patients.
    Migdalis IN, Hatzigakis SM, Dimakopoulos N, Tolis A, Likoudi A.
    J Med; 1996; 27(5-6):341-50. PubMed ID: 9151202
    [Abstract] [Full Text] [Related]

  • 4. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 5. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK, Chaturvedi N, Fuller J.
    Ugeskr Laeger; 1999 Feb 15; 161(7):949-52. PubMed ID: 10051804
    [Abstract] [Full Text] [Related]

  • 6. Urinary IgG4: an additional parameter in characterizing patients with incipient diabetic nephropathy.
    Gambardella S, Morano S, Cancelli A, Pietravalle P, Frontoni S, Bacci S, Di Mario U, Andreani D.
    Diabetes Res; 1989 Apr 15; 10(4):153-7. PubMed ID: 2612110
    [Abstract] [Full Text] [Related]

  • 7. Urinary dopamine, noradrenaline and adrenaline in type 2 diabetic patients with and without nephropathy.
    Murabayashi S, Baba T, Tomiyama T, Takebe K.
    Horm Metab Res; 1989 Jan 15; 21(1):27-32. PubMed ID: 2925152
    [Abstract] [Full Text] [Related]

  • 8. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH.
    Diabet Med; 2005 Jan 15; 22(1):14-20. PubMed ID: 15606685
    [Abstract] [Full Text] [Related]

  • 9. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun 15; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 10. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.
    Nephrol Dial Transplant; 2004 Nov 15; 19(11):2784-8. PubMed ID: 15328385
    [Abstract] [Full Text] [Related]

  • 11. Microalbuminuria in insulin dependent diabetes mellitus.
    Patel KL, Mhetras SB, Varthakavi PK, Merchant PC, Nihalani KD.
    J Assoc Physicians India; 1999 Jun 15; 47(6):589-95. PubMed ID: 10999154
    [Abstract] [Full Text] [Related]

  • 12. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
    Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR.
    Nephrology (Carlton); 2008 Dec 15; 13(6):492-9. PubMed ID: 18771471
    [Abstract] [Full Text] [Related]

  • 13. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
    Popławska-Kita A, Mierzejewska-Iwanowska B, Szelachowska M, Siewko K, Nikołajuk A, Kinalska I, Górska M.
    Diabetes Metab Res Rev; 2008 Dec 15; 24(4):310-7. PubMed ID: 18273859
    [Abstract] [Full Text] [Related]

  • 14. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G, Antic S, Vlahovic P, Djordjevic V, Zvezdanovic L, Stefanovic V.
    Ren Fail; 2007 Dec 15; 29(2):199-205. PubMed ID: 17365936
    [Abstract] [Full Text] [Related]

  • 15. [Significant risk factors for development of microalbuminuria and diabetic nephropathy in patients with non-insulin-dependent diabetes].
    Gall ML, Hougaard P, Borch-Johnsen K, Parving HH.
    Ugeskr Laeger; 1998 Jul 27; 160(31):4524-7. PubMed ID: 9700308
    [Abstract] [Full Text] [Related]

  • 16. Effect of tranilast in early-stage diabetic nephropathy.
    Soma J, Sato K, Saito H, Tsuchiya Y.
    Nephrol Dial Transplant; 2006 Oct 27; 21(10):2795-9. PubMed ID: 16820373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The significance of determination of urinary type IV collagen concentrations from a random urine collection in patients with non-insulin dependent diabetes mellitus].
    Kotajima N, Fukumura Y, Obata K, Kobayashi I.
    Rinsho Byori; 1998 Mar 27; 46(3):277-82. PubMed ID: 9564768
    [Abstract] [Full Text] [Related]

  • 19. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec 27; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 20. Urinary excretion of high molecular weight adiponectin is an independent predictor of decline of renal function in type 2 diabetes.
    Kopf S, Oikonomou D, von Eynatten M, Kieser M, Zdunek D, Hess G, Morcos M, Forsblom C, Bierhaus A, Groop PH, Nawroth PP, Humpert PM.
    Acta Diabetol; 2014 Dec 27; 51(3):479-89. PubMed ID: 24366425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.